Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
ARVINAS, INC. (ARVN) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 8-K Quarterly results
Docs: "Arvinas Reports Second Quarter 2023 Financial Results and Provides Corporate Update – Enrollment continues globally in multiple clinical studies of vepdegestrant , including VERITAC-2 2L Phase 3 trial and study lead-in for the VERITAC-3 1L Phase 3 trial, both in ER+/HER2- metastatic breast cancer –"
02/23/2023 8-K Quarterly results
Docs: "Arvinas Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update – Initiated multiple trials with ARV-471, including a 2L+ Phase 3 trial for patients with metastatic breast cancer –"
11/09/2022 8-K Quarterly results
08/05/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
02/28/2022 8-K Quarterly results
Docs: "Arvinas Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update"
11/03/2021 8-K Quarterly results
Docs: "Arvinas Reports Third Quarter 2021 Financial Results and Provides Corporate Update"
08/05/2021 8-K Quarterly results
05/04/2021 8-K Quarterly results
03/01/2021 8-K Quarterly results
11/05/2020 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Arvinas Reports Third Quarter 2020 Financial Results and Provides Corporate Update"
08/04/2020 8-K Quarterly results
04/28/2020 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : April 28, 2020 Arvinas, Inc. Delaware 001-38672 47-2566120 5 Science Park 395 Winchester Ave. New Haven, Connecticut 06511 Registrant's telephone number, including area code: 535-1456 Not applicable",
"Arvinas Reports First Quarter 2020 Financial Results and Provides a Corporate Update"
03/16/2020 8-K Quarterly results
11/04/2019 8-K Quarterly results
08/05/2019 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : August 5, 2019 Arvinas, Inc. Delaware 001-38672 47-2566120 5 Science Park 395 Winchester Ave. New Haven, Connecticut 06511 Registrant's telephone number, including area code: 535-1456 Not applicable",
"Arvinas Reports Second Quarter 2019 Financial Results and Provides Corporate Update"
05/08/2019 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : May 8, 2019 Arvinas, Inc. Delaware 001-38672 47-2566120 5 Science Park 395 Winchester Ave. New Haven, Connecticut 06511 Registrant's telephone number, including area code: 535-1456 Not applicable",
"Arvinas Reports First Quarter Financial Results and Provides Corporate Update"
04/01/2019 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : March 26, 2019 Arvinas, Inc. Delaware 001-38672 47-2566120 5 Science Park 395 Winchester Ave. New Haven, Connecticut 06511 Registrant's telephone number, including area code: 535-1456 Not applicable",
"Arvinas Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy